DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ribavirin (Ribavirin) - Hospitalization - Suspected Cause - Side Effect Reports

 
 



Index of reports > Hospitalization (837)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ribavirin hospitalization. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 837   Next >>

Possible Ribavirin side effects in

Reported by a consumer/non-health professional from Brazil on 2012-08-27

Patient:

Reactions: Breast Pain, Viral Load Increased, Varicose Vein Ruptured, Drug Ineffective, Pyrexia, Hypoaesthesia, Gynaecomastia, Malaise, Overdose, Swelling, Alopecia, Oedema Peripheral, Sensitivity of Teeth, Fluid Retention

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ribavirin
    Dosage: unk, bid
    Administration route: Oral
    Start date: 2012-04-01
    End date: 2012-06-18

Victrelis
    Dosage: unk, tid
    Administration route: Oral
    Start date: 2012-04-01
    End date: 2012-06-18

Ribavirin
    Dosage: unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2005-01-01
    End date: 2005-01-01

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-18
    End date: 2012-04-01

Ribavirin
    Dosage: unk
    Administration route: Oral
    Start date: 2011-12-01
    End date: 2012-04-01

Other drugs received by patient: Coumadin; Coumadin; Pegasys; Lansoprazole; Pegasys; Pegasys



Possible Ribavirin side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient: female

Reactions: Cardiac Failure Congestive

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ribavirin
    Indication: Hepatitis C
    Start date: 2007-11-15
    End date: 2008-10-01

Pegasys
    Indication: Hepatitis C
    Start date: 2007-11-15
    End date: 2008-10-01



Possible Ribavirin side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient: female

Reactions: Dehydration, Anaemia, Lower Respiratory Tract Inflammation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
VX-950
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-15

Ribavirin
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-02-15

PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-02-15



Possible Ribavirin side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient: female, weighing 83.0 kg (182.6 pounds)

Reactions: Tongue Ulceration, Thermoanaesthesia, Rash Pruritic, Oral Discomfort, Fatigue, Cough, Vomiting, Nausea, Haemorrhoids, Hypoaesthesia, Cognitive Disorder, Aptyalism, Anal Fissure, Anxiety, Throat Irritation, Diarrhoea, Dehydration, Insomnia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Incivek
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-07-27
    End date: 2012-08-04

Pegasys
    Dosage: 180 unk, unk
    Indication: Hepatitis C
    Start date: 2012-07-27
    End date: 2012-08-04

Ribavirin
    Dosage: 600 mg, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-07-27
    End date: 2012-08-04



Possible Ribavirin side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient: male, weighing 81.6 kg (179.6 pounds)

Reactions: Fatigue, Dizziness, Vision Blurred, Feeling Abnormal, Blood Glucose Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Incivek
    Dosage: 750 mg, tid
    Administration route: Oral
    Start date: 2012-08-12

Ribavirin
    Dosage: unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-07-14
    End date: 2012-08-12

Ribavirin
    Dosage: unk
    Administration route: Oral
    Start date: 2012-08-12

Pegasys
    Dosage: 180 unk, unk
    Start date: 2012-08-12

Pegasys
    Dosage: 180 unk, unk
    Indication: Hepatitis C
    Start date: 2012-07-14
    End date: 2012-08-03

Incivek
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-07-14
    End date: 2012-08-10



Possible Ribavirin side effects in male

Reported by a health professional (non-physician/pharmacist) from China on 2012-08-27

Patient: male, weighing 61.5 kg (135.3 pounds)

Reactions: Occult Blood, Anaemia, Faeces Discoloured

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2009-02-01
    End date: 2009-04-07

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2008-08-01
    End date: 2009-04-07

Other drugs received by patient: Sirolimus



Possible Ribavirin side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Anaemia, Rash, Haemolytic Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-03-16

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-04-24
    End date: 2012-05-21

Ribavirin
    Dosage: 500 mg, qd
    Administration route: Oral
    Start date: 2012-05-22

Ribavirin
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-21
    End date: 2012-04-03

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-03-16

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-02-27

Ribavirin
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-02-28
    End date: 2012-03-17

Ribavirin
    Dosage: 300 mg, qd
    Administration route: Oral
    Start date: 2012-04-04
    End date: 2012-04-23

PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-03-15

Other drugs received by patient: Coniel; Famotidine; Allopurinol; Celestamine (Betamethasone (+) Dexchlorpheniramine Maleate (+) Fluphen; Isosorbide Dinitrate



Possible Ribavirin side effects in

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient: , weighing 117.9 kg (259.4 pounds)

Reactions: Abscess Rupture, Peritonitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Incivek
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-07-18
    End date: 2012-08-01

Incivek
    Dosage: 750 mg, tid
    Administration route: Oral
    Start date: 2012-01-20
    End date: 2012-05-18

Ribavirin
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-07-18
    End date: 2012-05-18

Pegasys
    Dosage: 180 a?g, unk
    Indication: Hepatitis C
    Start date: 2011-07-18
    End date: 2012-05-18



Possible Ribavirin side effects in male

Reported by a pharmacist from United States on 2012-08-27

Patient: male, weighing 79.0 kg (173.8 pounds)

Reactions: Swelling Face, Neutropenia, Rash Pruritic

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Incivek
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-01

Pegasys
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-01

Ribavirin
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-01



Possible Ribavirin side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient: male, weighing 90.7 kg (199.5 pounds)

Reactions: Fatigue, Wrist Fracture, Diarrhoea, Liver Function Test Abnormal, Anaemia, Haemorrhoids, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ribavirin
    Dosage: 1000 mg, bid
    Administration route: Oral
    Indication: Hepatitis C
    End date: 2012-07-01

VX-950
    Dosage: unk
    Administration route: Oral

VX-950
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-07-01
    End date: 2011-10-01

Pegasys
    Dosage: 180 unk, unk
    Indication: Hepatitis C
    End date: 2012-07-01



Possible Ribavirin side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient:

Reactions: HIP Arthroplasty

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Simvastatin

Simvastatin

Ribavirin

Simvastatin

Blinded Narlaprevir

Simvastatin

Blinded Boceprevir

Simvastatin

Simvastatin

Peginterferon Alfa-2B

Placebo



Possible Ribavirin side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient: female

Reactions: Loss of Consciousness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ribavirin
    Dosage: 600 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-07-23

VX-950
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-07-23

Pegasys
    Dosage: 180 unk, unk
    Indication: Hepatitis C
    Start date: 2012-07-23



Possible Ribavirin side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-25

Patient: female

Reactions: Cholelithiasis, Weight Decreased, Peroneal Nerve Palsy, Fear, Transfusion, Asthenia, Myocardial Infarction, Blood Test Abnormal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ribavirin
    Indication: Hepatitis C
    Start date: 2011-09-16

Pegasys
    Indication: Hepatitis C
    Start date: 2011-09-16
    End date: 2012-06-27

Victrelis
    Indication: Hepatitis C
    End date: 2012-06-27

Ribavirin
    End date: 2012-06-27



Possible Ribavirin side effects in

Reported by a physician from United States on 2012-08-24

Patient:

Reactions: Intestinal Polyp, Gastrointestinal Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Telaprevir
    Dosage: 750 mg, q8h
    Administration route: Oral

Norvasc

PEG-Intron
    Dosage: unk, qw
    Indication: Hepatitis C
    Start date: 2012-02-16

Ribavirin
    Dosage: 600 mg, bid
    Administration route: Oral

Other drugs received by patient: Centrum (Minerals (Unspecified) (+) Vitamins (Unspecified)); Xanthophyll



Possible Ribavirin side effects in male

Reported by a pharmacist from United States on 2012-08-24

Patient: male

Reactions: Post Procedural Complication

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Dosage: 180mcg q week sq
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-07-10

Ribavirin
    Dosage: 1000mg daily po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-07-10



Possible Ribavirin side effects in 54 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24

Patient: 54 year old female

Reactions: Anxiety Disorder, Nausea, Insomnia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
VX-950
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-15
    End date: 2012-02-21

VX-950
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-02-22
    End date: 2012-05-08

PEG-Intron
    Indication: Hepatitis C
    Start date: 2012-02-15

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-15
    End date: 2012-02-28

Ribavirin
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-06-12

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-13
    End date: 2012-06-19

Ribavirin
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-06-20
    End date: 2012-07-31

Other drugs received by patient: Ursodiol; Loxonin; Loxonin; Omeprazole; Januvia; Loxonin



Possible Ribavirin side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-24

Patient: female, weighing 65.8 kg (144.8 pounds)

Reactions: Nausea, Haemorrhoids, Headache, Rash, Tremor, Loss of Consciousness, Dysgeusia, Haematochezia, Fatigue, Malaise, RED Blood Cell Count Decreased, Blood Potassium Decreased, Diarrhoea, Insomnia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ribavirin

Telaprevir
    Dosage: 375 mg 2 tablets tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-30
    End date: 2012-07-27

Pegasys
    Indication: Hepatitis C
    Start date: 2012-04-30

Ribavirin
    Dosage: divided doses
    Indication: Hepatitis C
    Start date: 2012-04-30

Other drugs received by patient: Cymbalta; Zofran; Vitamin D; Lisinopril; Omeprazole; Lasix; Trazodone Hydrochloride



Possible Ribavirin side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-24

Patient: male

Reactions: Hepatitis, Liver Transplant

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ribavirin
    Indication: Hepatitis C
    End date: 2006-01-01

Interferon
    Indication: Hepatitis C
    End date: 2006-01-01



Possible Ribavirin side effects in female

Reported by a pharmacist from United States on 2012-08-24

Patient: female

Reactions: Incoherent, RED Blood Cell Count Decreased, Faecal Incontinence, Fall

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Dosage: 90 mcg qw sq
    Indication: Hepatitis C
    Start date: 2012-05-30

Ribavirin
    Dosage: 400mg bid po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-30

Other drugs received by patient: Incivek



Possible Ribavirin side effects in

Reported by a physician from Argentina on 2012-08-24

Patient:

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Placebo
    Dosage: 2400 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-07-15
    End date: 2011-01-13

Simvastatin
    Dosage: 2400 mg, unk
    Administration route: Oral
    Start date: 2010-07-15
    End date: 2011-01-13

Peginterferon Alfa-2B
    Dosage: 2400 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-07-15
    End date: 2011-01-13

Simvastatin
    Dosage: 2400 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-07-15
    End date: 2011-01-13

Ribavirin
    Dosage: 2400 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-07-15
    End date: 2011-01-13

PEG-Intron
    Dosage: 150 units
    Indication: Hepatitis C
    Start date: 2010-07-15
    End date: 2011-01-06

Simvastatin
    Dosage: 2400 mg, unk
    Administration route: Oral
    Start date: 2010-07-15
    End date: 2011-01-13

Simvastatin
    Dosage: 2400 mg, unk
    Administration route: Oral
    Start date: 2010-07-15
    End date: 2011-01-13

Blinded Boceprevir
    Dosage: 2400 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-07-15
    End date: 2011-01-13

Simvastatin
    Dosage: 2400 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-07-15
    End date: 2011-01-13

Ribavirin
    Dosage: 2400 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-07-15
    End date: 2011-01-12

Simvastatin
    Dosage: 2400 mg, unk
    Administration route: Oral
    Start date: 2010-07-15
    End date: 2011-01-13



Possible Ribavirin side effects in 67 year old male

Reported by a pharmacist from United States on 2012-08-24

Patient: 67 year old male

Reactions: Drug Level Below Therapeutic, Anaemia, Deep Vein Thrombosis, Haematoma

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Telaprevir
    Dosage: 750mg, tid, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-06-05

Ribavirin
    Dosage: 600 mg, bid, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-06-05



Possible Ribavirin side effects in

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-08-23

Patient:

Reactions: Nephrolithiasis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ribavirin
    Dosage: 600 mg, qam
    Administration route: Oral
    Start date: 2010-02-15

Ribavirin
    Dosage: 600 mg, qam
    Administration route: Oral
    Start date: 2010-01-14
    End date: 2010-01-17

Vaniprevir
    Dosage: 600 mg, qam
    Start date: 2010-01-14
    End date: 2010-01-17

Ribavirin
    Dosage: 600 mg, qam
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2009-12-02
    End date: 2009-12-16

Ribavirin
    Dosage: 600 mg, qpm
    Administration route: Oral
    Start date: 2009-12-24
    End date: 2009-12-30

Vaniprevir
    Dosage: 600 mg, qam
    Indication: Hepatitis C
    Start date: 2009-12-02
    End date: 2009-12-16

Vaniprevir
    Dosage: 600 mg, qam
    Start date: 2010-01-19
    End date: 2010-02-13

Ribavirin
    Dosage: 600 mg, qpm
    Administration route: Oral
    Start date: 2009-12-02
    End date: 2009-12-22

Vaniprevir
    Dosage: 600 mg, qam
    Start date: 2010-02-15

Peginterferon Alfa-2B
    Dosage: 180 microgram, qw
    Indication: Hepatitis C
    Start date: 2009-12-02

Ribavirin
    Dosage: 600 mg, qpm
    Administration route: Oral
    Start date: 2010-01-01

Vaniprevir
    Dosage: 600 mg, qam
    Start date: 2009-12-18
    End date: 2009-12-31

Ribavirin
    Dosage: 600 mg, qam
    Administration route: Oral
    Start date: 2010-01-02
    End date: 2010-01-12

Ribavirin
    Dosage: 600 mg, qam
    Administration route: Oral
    Start date: 2010-01-19
    End date: 2010-02-13

Vaniprevir
    Dosage: 600 mg, qam
    Start date: 2010-01-02
    End date: 2010-01-12

Ribavirin
    Dosage: 600 mg, qam
    Administration route: Oral
    Start date: 2009-12-18
    End date: 2009-12-31

Vaniprevir
    Dosage: 600 mg, qpm
    Start date: 2009-12-02
    End date: 2009-12-22

Vaniprevir
    Dosage: 600 mg, qpm
    Start date: 2009-12-24
    End date: 2009-12-30

Vaniprevir
    Dosage: 600 mg, qpm
    Start date: 2010-01-01

Other drugs received by patient: Ibuprofen; Opipramol Hydrochloride



Possible Ribavirin side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Sudden Hearing Loss

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ribavirin
    Dosage: 4 df, qd
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Peginterferon Alfa-2B
    Dosage: 4 unk, unk
    Administration route: Oral
    Start date: 2012-04-06
    End date: 2012-06-20

Ribavirin
    Dosage: 2 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-10
    End date: 2012-01-10

Blinded Vaniprevir
    Dosage: 2 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-10
    End date: 2012-01-10

Ribavirin
    Dosage: 2 df, unk
    Administration route: Oral
    Start date: 2012-04-05
    End date: 2012-04-05

Simvastatin
    Dosage: 2 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-10
    End date: 2012-01-10

Placebo
    Dosage: 4 df, qd
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Placebo
    Dosage: 4 unk, unk
    Administration route: Oral
    Start date: 2012-04-06
    End date: 2012-06-20

Blinded Vaniprevir
    Dosage: 4 unk, unk
    Administration route: Oral
    Start date: 2012-04-06
    End date: 2012-06-20

Rebetol
    Dosage: 3 df, qd
    Administration route: Oral
    Start date: 2012-05-31
    End date: 2012-07-19

Simvastatin
    Dosage: 4 df, qd
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Vaniprevir
    Dosage: 2 df, unk
    Administration route: Oral
    Start date: 2012-04-05
    End date: 2012-04-05

Simvastatin
    Dosage: 4 unk, unk
    Administration route: Oral
    Start date: 2012-04-06
    End date: 2012-06-20

Rebetol
    Dosage: 2 df, unk
    Administration route: Oral
    Start date: 2012-04-05
    End date: 2012-04-05

Rebetol
    Dosage: 3 df, unk
    Administration route: Oral
    Start date: 2012-04-06
    End date: 2012-05-16

Peginterferon Alfa-2B
    Dosage: 4 df, qd
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Simvastatin
    Dosage: 4 df, qd
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Vaniprevir
    Dosage: 4 df, qd
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Ribavirin
    Dosage: 4 unk, unk
    Administration route: Oral
    Start date: 2012-04-06
    End date: 2012-06-20

PEG-Intron
    Dosage: 80 unk, unk
    Start date: 2012-05-10
    End date: 2012-07-19

Rebetol
    Dosage: 3 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-10
    End date: 2012-04-04

Rebetol
    Dosage: 1 df, qd
    Administration route: Oral
    Start date: 2012-07-19
    End date: 2012-07-19

Peginterferon Alfa-2B
    Dosage: 2 df, unk
    Administration route: Oral
    Start date: 2012-04-05
    End date: 2012-04-05

Placebo
    Dosage: 2 df, unk
    Administration route: Oral
    Start date: 2012-04-05
    End date: 2012-04-05

Simvastatin
    Dosage: 2 df, unk
    Administration route: Oral
    Start date: 2012-04-05
    End date: 2012-04-05

Simvastatin
    Dosage: 2 df, unk
    Administration route: Oral
    Start date: 2012-04-05
    End date: 2012-04-05

PEG-Intron
    Dosage: 80 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-01-10
    End date: 2012-01-17

PEG-Intron
    Dosage: 80 microgram, qw
    Start date: 2012-01-26
    End date: 2012-05-02

Peginterferon Alfa-2B
    Dosage: 2 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-10
    End date: 2012-01-10

Placebo
    Dosage: 2 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-10
    End date: 2012-01-10

Simvastatin
    Dosage: 2 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-10
    End date: 2012-01-10

Simvastatin
    Dosage: 4 unk, unk
    Administration route: Oral
    Start date: 2012-04-06
    End date: 2012-06-20

Rebetol
    Dosage: 2 df, unk
    Administration route: Oral
    Start date: 2012-05-17
    End date: 2012-05-30

Other drugs received by patient: Loxoprofen; Rebamipide; Loxoprofen



Possible Ribavirin side effects in

Reported by a physician from Brazil on 2012-08-23

Patient:

Reactions: Apparent Death, Panic Attack, Depression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ribavirin
    Dosage: unk, bid
    Administration route: Oral
    Indication: Hepatitis
    Start date: 2012-06-01

Victrelis
    Dosage: unk, tid
    Administration route: Oral
    Indication: Hepatitis
    Start date: 2012-05-01
    End date: 2012-06-01

Other drugs received by patient: Interferon (Unspecified)



Possible Ribavirin side effects in

Reported by a physician from Germany on 2012-08-23

Patient:

Reactions: Facial Paresis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Boceprevir
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-12

Simvastatin
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-12

Blinded MK-5172
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-12

Simvastatin
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-12

PEG-Intron
    Dosage: 0.5 ml, qw
    Indication: Hepatitis C
    Start date: 2011-12-13
    End date: 2012-07-27

Peginterferon Alfa-2B
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-12

Rebetol
    Dosage: 3 df, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-12
    End date: 2012-07-30

Blinded Therapy
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-09

Placebo
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-12

Ribavirin
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-12

Other drugs received by patient: Amlodipine; Acetaminophen



Possible Ribavirin side effects in

Reported by a physician from France on 2012-08-23

Patient:

Reactions: Mass, Sepsis, Glomerulonephropathy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Acetaminophen
    Dosage: 1000 mg, qd
    Indication: Influenza Like Illness
    Start date: 2011-11-15

Boceprevir
    Dosage: 2400 mg, qd
    Indication: Hepatitis C
    Start date: 2011-12-13

Ribavirin
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2011-11-15

Peginterferon Alfa-2B
    Dosage: 80 microgram, qw
    Indication: Hepatitis C
    Start date: 2011-11-15

Truvada
    Dosage: 1 df, qod
    Indication: HIV Infection
    Start date: 2007-01-23

Other drugs received by patient: Norvir; Sertraline Hydrochloride; Plavix; Tamsulosin Hydrochloride; Crestor; Levocarnil; Crestor; Neorecormon; Dexeryl Tablets; Reyataz



Possible Ribavirin side effects in

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient:

Reactions: Blood Glucose Decreased, RED Blood Cell Count Decreased, Insomnia, Blood Glucose Fluctuation, DRY Skin, Decreased Appetite, Skin Fissures

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Dosage: 180 microgram, qw
    Indication: Chronic Hepatitis
    Start date: 2011-10-07

Victrelis
    Dosage: 4 df, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-11

Ribavirin
    Dosage: 1200 mg, qd
    Indication: Hepatitis C
    Start date: 2011-10-07

Other drugs received by patient: Insulin



Possible Ribavirin side effects in

Reported by a physician from Poland on 2012-08-23

Patient:

Reactions: Lymphadenopathy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Boceprevir
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2010-07-29

Viread
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-05-18

Boceprevir
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-07-29

Lopinavir and Ritonavir
    Dosage: 2 df, bid
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-05-18

Ribavirin
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-07-01

Boceprevir
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2010-07-29

Peginterferon Alfa-2B
    Dosage: 80 microgram, qw
    Indication: Hepatitis C
    Start date: 2010-07-01

Epivir
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-05-18

Boceprevir
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2010-07-29

Other drugs received by patient: Bebetina; Bebetina; Bebetina; Bebetina



Possible Ribavirin side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-23

Patient: 50 year old male

Reactions: Abdominal Discomfort, Malaise

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ribavirin
    Dosage: 800 mg, qd
    Administration route: Oral
    Start date: 2012-05-24
    End date: 2012-06-06

Ribavirin
    Dosage: 600 unk, unk
    Administration route: Oral
    Start date: 2012-06-07
    End date: 2012-07-19

VX-950
    Dosage: unk
    Administration route: Oral

Ribavirin
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-03-08
    End date: 2012-03-13

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-14
    End date: 2012-05-01

Ribavirin
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-03
    End date: 2012-03-07

Peginterferon Alfa-2B
    Dosage: 1.5 a?g/kg, unk
    Indication: Hepatitis C
    Start date: 2012-02-03
    End date: 2012-07-12

VX-950
    Dosage: 2250 mg, qd
    Indication: Hepatitis C
    Start date: 2012-02-03
    End date: 2012-03-06

VX-950
    Dosage: 1500 mg, qd
    Start date: 2012-03-07
    End date: 2012-04-26

Ribavirin
    Dosage: 600 unk, unk
    Administration route: Oral
    Start date: 2012-05-02
    End date: 2012-05-23



Possible Ribavirin side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ribavirin
    Dosage: 1000 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-02-09
    End date: 2010-03-02

Peginterferon Alfa-2B
    Dosage: 120 mcg, qw
    Indication: Hepatitis C
    Start date: 2010-02-09
    End date: 2010-03-08

Other drugs received by patient: Metoprolol Tartrate; Aciphex; Ascorbic Acid (+) Folic Acid (+) Vitamin B Complex; Lipitor; Synthroid



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012